在接受机械血栓切除术的急性缺血性中风患者中,非传统的脂质参数和徒劳的再通道化之间的关联
Jia Duan1, Jian Duan1, Longyi Zheng2
1Department of Cerebrovascular Disease, Suining Central Hospital, No.27 of Dongping North Road, Hedong New District, Suining, 629000, Sichuan, China.
European journal of medical research
|August 19, 2025
概括
非传统的脂质参数如AIP,Apo B/A1,CRI-I和CRI-II与机械血栓切除术后急性大动脉封闭后徒劳的再通道化有关. 这些标志物可以预测中风患者的结果和最终心脏病发作量.
科学领域:
- 心血管研究研究心血管研究
- 神经学 神经学
- 生物标志物发现发现
背景情况:
- 非传统的脂质参数是急性缺血性中风 (AIS) 结果的重要生物标志物.
- 它们与急性大动脉封闭 (LAO) 机械血栓切除术 (MT) 后徒劳的再通道 (FR) 的关联需要进一步调查.
研究的目的:
- 探索非传统的脂质参数和机械血栓切除术 (MT) 后急性大动脉封闭 (LAO) 后徒劳的再通道 (FR) 之间的关系.
- 确定FR的独立风险因素及其与最终心脏病发作量的相关性.
主要方法:
- 对338名为LAO接受MT的患者进行了回顾性研究.
- 评估了血的有机体指数 (AIP),阿波利波蛋白 (Apo) B/A1比率,卡斯特利风险指数 (CRI-I,CRI-II) 和其他脂质参数.
- 利用多变量回归,受限立方线和线性回归来分析FR和心脏病发作体积.
主要成果:
- 在56.5%的患者中发生了无效的再通道化 (FR).
- 较高的AIP,Apo B/A1比率,CRI-I和CRI-II水平与FR的风险增加有显著的关联.
- AIP和CRI-II显示了与最终心脏病发作体积的正相关性.
结论:
- 原性血指数 (AIP),Apo B/A1比率,CRI-I和CRI-II是急性LAO中MT后FR的独立风险因素.
- 这些脂质参数作为新的预后生物标志物用于接受MT的患者.
相关概念视频
Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...


